These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 31387788)

  • 1. Asthma from immune pathogenesis to precision medicine.
    Khalaf K; Paoletti G; Puggioni F; Racca F; De Luca F; Giorgis V; Canonica GW; Heffler E
    Semin Immunol; 2019 Dec; 46():101294. PubMed ID: 31387788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine.
    Schoettler N; Strek ME
    Chest; 2020 Mar; 157(3):516-528. PubMed ID: 31678077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
    Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
    MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-life studies of biologics used in asthma patients: key differences and similarities to trials.
    Heffler E; Paoletti G; Giorgis V; Puggioni F; Racca F; Del Giacco S; Bagnasco D; Caruso C; Brussino L; Rolla G; Canonica GW
    Expert Rev Clin Immunol; 2019 Sep; 15(9):951-958. PubMed ID: 31389304
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe asthma phenotypes and endotypes.
    Agache I
    Semin Immunol; 2019 Dec; 46():101301. PubMed ID: 31466925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologics in asthma--the next step toward personalized treatment.
    Darveaux J; Busse WW
    J Allergy Clin Immunol Pract; 2015; 3(2):152-60; quiz 161. PubMed ID: 25754716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies and opportunities in severe asthma.
    Humbert M; Busse W; Hanania NA
    Curr Opin Pulm Med; 2018 Jan; 24(1):83-93. PubMed ID: 29059087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypes/endotypes-driven treatment in asthma.
    Braido F; Tiotiu A; Kowal K; Mihaicuta S; Novakova P; Oguzulgen IK
    Curr Opin Allergy Clin Immunol; 2018 Jun; 18(3):184-189. PubMed ID: 29601354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision medicine in asthma: linking phenotypes to targeted treatments.
    Chung KF
    Curr Opin Pulm Med; 2018 Jan; 24(1):4-10. PubMed ID: 29036018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving phenotypes to endotypes: is precision medicine achievable in asthma?
    Bagnasco D; Passalacqua G; Caminati M; Heffler E; Menzella F; De Ferrari L; Riccio AM; Folli C; Canonica GW
    Expert Rev Respir Med; 2020 Feb; 14(2):163-172. PubMed ID: 31899999
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in asthma: New understandings of asthma's natural history, risk factors, underlying mechanisms, and clinical management.
    Miller RL; Grayson MH; Strothman K
    J Allergy Clin Immunol; 2021 Dec; 148(6):1430-1441. PubMed ID: 34655640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of asthma endotypes: implications for therapy.
    Stokes JR; Casale TB
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):121-5. PubMed ID: 27499539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma Phenotypes and Endotypes: Implications for Personalised Therapy.
    Dean K; Niven R
    BioDrugs; 2017 Oct; 31(5):393-408. PubMed ID: 28879503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.
    Rogers L; Jesenak M; Bjermer L; Hanania NA; Seys SF; Diamant Z
    Respir Med; 2023 Nov; 218():107414. PubMed ID: 37776915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Treatments for Asthma.
    Huang J; Pansare M
    Pediatr Clin North Am; 2019 Oct; 66(5):925-939. PubMed ID: 31466682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to compare the efficacy of biologic agents in asthma.
    Viswanathan RK; Busse WW
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):137-149. PubMed ID: 32387169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From phenotypes to endotypes to asthma treatment.
    Agache IO
    Curr Opin Allergy Clin Immunol; 2013 Jun; 13(3):249-56. PubMed ID: 23587683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma phenotypes and endotypes.
    Lin TY; Poon AH; Hamid Q
    Curr Opin Pulm Med; 2013 Jan; 19(1):18-23. PubMed ID: 23114560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers.
    Santus P; Saad M; Damiani G; Patella V; Radovanovic D
    Pharmacol Res; 2019 Aug; 146():104296. PubMed ID: 31173886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood asthma heterogeneity at the era of precision medicine: Modulating the immune response or the microbiota for the management of asthma attack.
    Lejeune S; Deschildre A; Le Rouzic O; Engelmann I; Dessein R; Pichavant M; Gosset P
    Biochem Pharmacol; 2020 Sep; 179():114046. PubMed ID: 32446884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.